-
Cytokinetics’ cardiovascular pipeline beats strong
10 May 2024 12:38 GMT
… to phase 2.
Omecamtiv mecarbil
Cytokinetics is also developing omecamtiv mecarbil, a cardiac muscle …
-
Cytokinetics Reports First Quarter 2024 Financial Results
08 May 2024 20:00 GMT
… the Journal of Cardiac Failure.
omecamtiv mecarbil (cardiac myosin activator) Withdrew the … Medicines Agency (EMA) for omecamtiv mecarbil based on feedback from the … HCM. Cytokinetics is also developing omecamtiv mecarbil, a cardiac muscle activator, in …
-
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
08 May 2024 11:30 GMT
… HCM. Cytokinetics is also developing omecamtiv mecarbil, a cardiac muscle activator, in …
-
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
08 May 2024 11:30 GMT
… (HCM). Cytokinetics is also developing omecamtiv mecarbil, a cardiac muscle activator, in …
-
Cytokinetics to Hold Annual Meeting of Stockholders
07 May 2024 20:00 GMT
… HCM. Cytokinetics is also developing omecamtiv mecarbil, a cardiac muscle activator, in …
-
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
07 May 2024 18:08 GMT
… . Among its drug candidates is omecamtiv mecarbil, a novel cardiac myosin activator …
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 May 2024 20:00 GMT
… HCM. Cytokinetics is also developing omecamtiv mecarbil, a cardiac muscle activator, in …
-
FDA Declines Approval for Omecamtiv Mecarbil in HFrEF
01 Mar 2023 20:08 GMT
… advisers recommended against approval of omecamtiv mecarbil for chronic HFrEF, as reported … by theheart.org | Medscape Cardiology, omecamtiv mecarbil produced a positive result for … an additional clinical trial of omecamtiv mecarbil are required to establish …
-
Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil
28 Feb 2023 22:31 GMT
… Drug Application (NDA) for omecamtiv mecarbil, an investigational, selective, … access the call. About Omecamtiv Mecarbil Omecamtiv mecarbil is an investigational, selective, … research has shown that omecamtiv mecarbil increases cardiac contractility without …
-
FDA Panel Votes No on Omecamtiv Mecarbil for Heart Failure
14 Dec 2022 21:19 GMT
… has recommended against approval of omecamtiv mecarbil (Cytokinetics) for the treatment of … reduced ejection fraction (HFrEF).
Omecamtiv mecarbil is a first-in-class … by theheart.org | Medscape Cardiology, omecamtiv mecarbil produced a positive result for …